Neuro42 was founded by Amit Vohra in 2020.

Who are Neuro42's investors?

Neuro42's investors include Frontier Path VC, ShangBay Capital LLC.

How much funding has Neuro42 raised?

Neuro42 has disclosed $22.2M raised across 2 rounds.

Where is Neuro42 headquartered?

Neuro42 is headquartered in San Francisco, US.

Neuro42

San Francisco, US · Founded 2020 · Delaware corporation · 2 known investors

Find your way into Neuro42

94 people in our graph share verified history with the Neuro42 team — schools, employers, funds. One of them is your warm intro.

Andrea Echstenkamperunlockedknows Amit Vohra · together at University of Florida (overlapped)

×5knows the team · via University of Florida

×6knows the team · via Duke University - The Fuqua School of Business

neuro42 develops a portable, FDA 510(k)-cleared MRI platform that brings neurological imaging directly to the patient rather than requiring transport to a facility. The system supports point-of-care diagnosis and image-guided, minimally invasive neurological procedures for physicians and patients.

Deep Tech Healthtech Medical Devices

Founders & leadership

Neuro42 was founded in 2020 by Amit Vohra.

Amit Vohra inFounder & CEOAmit Vohra is an executive with experience in medical device, biotechnology, and technology companies, with expertise in business strategy, operations management, product development, and commercialization across healthcare and life sciences sectors.

Abhita BatraNamed on SEC filing

Shibu GangadharanNamed on SEC filing

Board

Krishna R. BhupalBoard director

Rahul TalwarBoard director

Investors · 2

Frontier Path VCLondon

ShangBay Capital LLCPalo Alto

Reported raises · per SEC filings

Form D private placements

$22.2M disclosed across 2 rounds · 2024

▶$15.6MraisedSep 2024 · 85 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Krishna R. BhupalDirector
Amit VohraExecutive Officer, Director
Rahul TalwarDirector
Abhita BatraExecutive Officer, Director

Offering amount: $36.6M
Amount sold: $15.6M
Minimum investment: $1
First sale: Sep 2024
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$6.7MraisedJun 2024 · 24 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Krishna R. BhupalDirector
Abhita BatraExecutive Officer, Director
Amit VohraExecutive Officer, Director
Shibu GangadharanExecutive Officer

Offering amount: $7.3M
Amount sold: $6.7M
Minimum investment: $1
First sale: May 2024
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Moshlife124 shared keywordsMOSH makes protein bars formulated with brain-focused ingredients such as creatine, lion's mane, and ashwagandha, marketed to support brain health. The consumer packaged food brand also funds Alzheimer's research through product purchases.

Thrive Market115 shared keywordsThrive Market is an online grocery delivery service offering non-GMO and clean label food products at discounted prices through a membership model. The company targets health-conscious consumers seeking healthier alternatives to conventional groceries.

Companies competing with Neuro42 for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase I	2023	$484.6K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Neuro42 adds $6.5M to its coffers | AuntMinnieauntminnie.com · Jul 2021

Frequently asked questions

What does Neuro42 do?: neuro42 develops a portable, FDA 510(k)-cleared MRI platform that brings neurological imaging directly to the patient rather than requiring transport to a facility. The system supports point-of-care diagnosis and image-guided, minimally invasive neurological procedures for physicians and patients.
Who founded Neuro42?: Neuro42 was founded by Amit Vohra in 2020.
Who are Neuro42's investors?: Neuro42's investors include Frontier Path VC, ShangBay Capital LLC.
How much funding has Neuro42 raised?: Neuro42 has disclosed $22.2M raised across 2 rounds.
Where is Neuro42 headquartered?: Neuro42 is headquartered in San Francisco, US.